| 2023 | Machine-Learning Model for the Prediction of Hypoxaemia during Endoscopic Retrograde Cholangiopancreatography under Monitored Anaesthesia Care
| YONSEI MEDICAL JOURNAL |
| 2022 | Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
| CANCERS |
| 2022 | Efficacy and safety of temperature-controlled intraductal radiofrequency ablation in advanced malignant hilar biliary obstruction: A pilot multicenter randomized comparative trial | JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES |
| 2021 | Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer | EBIOMEDICINE |
| 2021 | Peripheral natural killer cell activity is associated with poor clinical outcomes in pancreatic ductal adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2020 | Radiographic portal or superior mesenteric vein invasion is an independent prognostic factor in non-metastatic pancreatic ductal adenocarcinoma: A missing block of clinical T staging? | PANCREATOLOGY |
| 2020 | Single-center risk factor analysis for FOLFIRINOX associated febrile neutropenia in patients with pancreatic cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2020 | FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
| 2020 | Preoperative prediction of futile surgery in patients with radiologically resectable or borderline resectable pancreatic adenocarcinoma | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2019 | KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study | HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL |
| 2018 | Multicenter phase II trial of modified FOLFIRINOX in gemcitabine-refractory pancreatic cancer
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
| 2018 | Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
| WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY |
| 2017 | Efficacy and treatment-related adverse events of gemcitabine plus nab-paclitaxel for treatment of metastatic pancreatic cancer "in a Korean" population: A single-center cohort study | SEMINARS IN ONCOLOGY |
| 2017 | Association between Metformin Use and Risk of Lactic Acidosis or Elevated Lactate Concentration in Type 2 Diabetes
| YONSEI MEDICAL JOURNAL |
| 2016 | Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club | GUT |
| 2015 | The optimal serum pepsinogen cut-off value for predicting histologically confirmed atrophic gastritis | DIGESTIVE AND LIVER DISEASE |
| 2014 | 다발성 글루카곤 생성 내분비세포종을 동반한 췌장 알파세포의 Nesidioblastosis 및 과다증식 1예
| Korean Journal of Gastroenterology |
| 2014 | Full-dose gemcitabine is a more effective chemotherapeutic agent than 5-fluorouracil for concurrent chemoradiotherapy as first-line treatment in locally advanced pancreatic cancer | CHEMOTHERAPY |
| 2014 | A Case of Rectal Squamous Cell Carcinoma with Metachronous Diffuse Large B Cell Lymphoma in an HIV-Infected Patient.
| INFECTION AND CHEMOTHERAPY |
| 2014 | Gemcitabine-Induced Hemolytic Uremic Syndrome in Pancreatic Cancer: A Case Report and Review of the Literature
| GUT AND LIVER |
| 2013 | A Case of Rapidly Progressive Primary Sclerosing Cholangitis Requiring Liver Transplantation
| Journal of the Korean Society for Transplantation |
| 2013 | The Use of Health Functional Foods in Gastrointestinal Cancer Patients
| Clinical Nutrition Research |
http://orcid.org/0000-0003-1790-0809
